by McKesson Ventures | Mar 3, 2022 | Press Releases
CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, has closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. Other investors participating in the...
by McKesson Ventures | Feb 17, 2022 | Press Releases
IVX Health recently announced the opening of three new centers in Florida’s Southwest in the spring. The centers will be located in the communities of Fort Myers, Naples, and Estero. The company is known as a nationwide provider of injection and infusion therapy...
by McKesson Ventures | Feb 7, 2022 | Press Releases
Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...
by McKesson Ventures | Jan 25, 2022 | Press Releases
Technology-enabled service provider Reimagine Care is a leader in promoting support for oncologists by delivering valuable, home-centered cancer care. It recently announced that a $25 million capital raise has been completed. Led by LRVHealth, Santé Ventures, and...
by McKesson Ventures | Jan 20, 2022 | Portfolio News
Glassdoor, a provider of insights about companies and jobs, recently announced its list of the best small to medium businesses in the United States to work in the coming year. Taking the 45th spot on this list is primary care support company Aledade. Aledade has a...
